Allarity Therapeutics Reports Progress in Stenoparib Development
Allarity Therapeutics provided updates on its DRP technology, patent acquisitions, and CLIA lab certification, all aimed at supporting the clinical development of stenoparib.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.